Ceres Inc  

(Public, NASDAQ:CERE)   Watch this stock  
Find more results for CERE
-0.009 (-3.07%)
Nov 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.25 - 0.29
52 week 0.22 - 1.82
Open 0.29
Vol / Avg. 467,663.00/183,927.00
Mkt cap 13.49M
P/E     -
Div/yield     -
EPS -1.08
Shares 48.19M
Beta     -
Inst. own 36%
Jan 7, 2015
Q1 2015 Ceres Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 20, 2014
Q4 2014 Ceres Inc Earnings Call
Nov 20, 2014
Q4 2014 Ceres Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (May '14) 2013
Net profit margin -958.68% -620.08%
Operating margin -957.20% -621.59%
EBITD margin - -585.12%
Return on average assets -98.92% -61.10%
Return on average equity -116.99% -68.04%
Employees 85 -
CDP Score - -


1535 Rancho Conejo Boulevard
Thousand Oaks, CA 91320
United States - Map
+1-805-3766500 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Ceres, Inc. (Ceres) is an agricultural biotechnology company selling seeds to produce renewable biomass feedstocks. The Company�s large-scale commercial products are sweet sorghum varieties that can be used as a drop-in feedstock to extend the operating season of Brazilian sugarcane-to-ethanol mills. Its products include sweet sorghum, high biomass sorghum, switchgrass, miscanthus and row crops. Its energy crops can also be used for the production of second-generation biofuels and bio-based chemicals, including cellulosic ethanol, butanol, jet fuel, diesel-like molecules and gasoline-like molecules, from non-food biomass. Baseload utility scale electric power can also be generated from the biomass feedstocks grown from its seeds. Ceres has sold switchgrass and high biomass sorghum seeds in the United States under its Blade Energy Crops (Blade) brand. In January 2010, the Company incorporated a subsidiary, Ceres Sementes do Brasil Ltda.

Officers and directors

Richard William Hamilton Ph.D. President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Paul M. Kuc Chief Financial Officer
Age: 51
Bio & Compensation  - Reuters
Wilfriede van Assche Senior Vice President, General Counsel and Secretary
Age: 59
Bio & Compensation  - Reuters
J. Jefferson Gwyn Ph.D. Vice President - Breeding and Genomics
Age: 55
Bio & Compensation  - Reuters
Roger Pennell Ph.D. Vice President - Trait Development
Age: 54
Bio & Compensation  - Reuters
Cheryl P. Morley Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Richard Bailey Flavell Ph.D., FRS, CBE Director
Age: 69
Bio & Compensation  - Reuters
Pascal Brandys Independent Director
Bio & Compensation  - Reuters
Raymond Debbane Independent Director
Age: 58
Bio & Compensation  - Reuters
Daniel Glat Independent Director
Age: 57
Bio & Compensation  - Reuters